[1] Paez J G, Janne P A, Lee J C, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy[J]. Science, 2004,304(5676): 1497
[2] Liang W, Zhang Y, Kang S, et al. Impact of EGFR mutation status on tumor response and progression free survival after first-line chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis[J]. J Thorac Dis, 2014,6(9): 1239
[3] Serrano M J, Ortega F G, Alvarez-Cubero M J, et al., EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer[J]. Oncotarget, 2014,5(17): 7486
[4] Boeckx C, Weyn C, Vanden Bempt I, et al. Mutation analysis of genes in the EGFR pathway in head and neck cancer patients: implications for anti-EGFR treatment response[J]. BMC Res Notes, 2014,7: 337
[5] Henriksen L, Grandal M V, Knudsen S L, et al. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands[J]. PLoS One, 2013,8(3): e5814
[6] 范瑾瑾, 骆宁, 董秀清,等. 不同固定剂在激光共聚焦荧光技术中的效果评价[J]. 中山大学学报(医学科学版), 2009,30(5): 600
[7] 林哲绚, 罗红军, 李慧,等. 免疫荧光技术中不同固定剂对细胞p65核移位观察效果的影响[J]. 山西医药杂志, 2012(3): 211
作者简介 冯婧文(1984-),女,硕士在读,研究方向:生物化学与分子生物学; 通信作者:肖春花,E-mail:xxcchh2002@163.com。